VOGEL Pierre, Hon. Prof. – Publications

Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies

P. Biniecka; S. Matsumoto; A. Belotti; J. Joussot; J. F. Bai et al. 

Structure-based optimization of type III indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors

U. F. Roehrig; S. R. Majjigapu; P. Vogel; A. Reynaud; F. Pojer et al. 

Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer

J-F. Bai; S. R. Majjigapu; B. Sordat; S. Poty; P. Vogel et al. 

Organic Chemistry and Synthesis Rely More and More upon Catalysts

P. Vogel; K. N. Houk 

Expeditious Asymmetric Synthesis of Polypropionates Relying on Sulfur Dioxide-Induced C-C Bond Forming Reactions

P. Vogel; J. A. Sordo Gonzalo 

Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors

U. F. Rohrig; S. R. Majjigapu; A. Reynaud; F. Pojer; N. Dilek et al. 

Trading mechanisms in over-the-counter markets

Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)

U. F. Rohrig; A. Reynaud; S. R. Majjigapu; P. Vogel; F. Pojer et al. 

Search for a standard model-like Higgs boson in the mass range between 70 and 110 GeV in the diphoton final state in proton-proton collisions at $\sqrt{s}=$ 8 and 13 TeV

A. M. Sirunyan; A. Tumasyan; W. Adam; F. Ambrogi; E. Asilar et al. 

Combinations of single-top-quark production cross-section measurements and |f$_{LV}$V$_{tb}$| determinations at $ \sqrt{s} $ = 7 and 8 TeV with the ATLAS and CMS experiments

M. Aaboud; G. Aad; B. Abbott; D. C. Abbott; O. Abdinov et al.